Time bonuses will be awarded at the finish of each stage, with 10, 6 and 4 seconds awarded to the first, second and third riders, respectively. 2025 Tour de France stage 1 preview ...

Sanofi eyes filings for multiple sclerosis therapy tolebrutinib, although two of three phase 3 trials miss their primary endpoints.

Mesoblast has secured FDA approval for the first-ever mesenchymal stem cell (MSC) therapy, Ryoncil for acute GvHD in children undergoing HSCT.